Abstract A significant reduction of kallikrein activity in urine (assayed by its amidolytic activity) was found in 64 normotensive workers who had been exposed to cadmium for 11 years on average and whose cadmium concentrations in urine ranged from 2-2 to 33-1 uglg creatimine.
The mean (geometric) urinary kallikrein activity (in UIg creatinine) amounted to 0-52 (range 011-1 90) in the control group (n = 193) against 039 (range 0-101-03) in the cadmium group, and the prevalence of abnormally low activity levels (. <020 U/g creatinine) amounted to 17-2% in the cadmium group against 5-2% in the control group. A reduction of aldosterone release (aldosterone in urine) associated with an increased natriuresis was also observed. This might constitute a compensatory mechanism maintaining blood pressure in the normal range. These biological effects of cadmium were not reversible after removal from exposure. This study indicates that cadmium can induce an irreversible toxic effect in the distal nephron. It also suggests that an excessive cadmium body burden alone may not be sufficient to induce hypertension, but in individuals whose blood pressure regulation may be impaired by other factors cadmium could stimulate the development of hypertension. This study also supports the recommendation to prevent hypertensive subjects from being exposed to cadmium. There was no indication that moderate exposure to mercury vapour (n = 53; mercury in urine, range 11-224 pg/g creatinine; average duration of exposure: six years) or to inorganic lead (n = 23; lead in blood, range 40-67 pg/100 ml; average duration of exposure: eight
The kidney occupies a key position in the regulation of blood pressure. Since it is also the target organ after excessive long term exposure to heavy metals such as cadmium (Cd), mercury 4.4.21.35) in the urine of workers exposed to heavy metals (Cd, Hg, or Pb) who had normal blood pressure. In the Cd group and its corresponding control group the integrity of the prohypertensive renin angiotensin aldosterone system was also assessed by monitoring the urinary concentration of aldosterone. Electrolyte concentrations in plasma and in urine, creatinine and fl,-microglobulin in serum, and the urinary concentration of total proteins, aminoacids, and three proteins (albumin, retinol binding protein, f,2-microglobulin) were also measured.
Subjects and methods

STUDY POPULATION
The total study population comprised 419 male workers divided into 192 metal exposed and 227 control subjects. The group of exposed subjects consisted of three subgroups: (1) a Cd group of 97 workers exposed to Cd dust and fume in two Cd smelters (29 were already retired or removed from exposure at the time of the survey); (2) a Hg group of 58 workers currently exposed to Hg vapour (chloralkali plant, manufacture of alkaline batteries), and (3) a Pb group of 37 workers currently exposed to Pb dust and fume (Pb smelter, ceramic manufacturing plant).
The definitive selection of the study population was based on the results of biological analyses and clinical examination at the time of the survey and on information gathered by a questionnaire mainly related to medical and occupational history.
The following criteria were adopted: (1) The control subjects had never been occupationally exposed to Cd, Pb, or Hg and at the time of the survey their concentrations of lead (PbB) in blood, and of cadmium (CdU) and mercury (HgU) in urine were normal-that is, PbB <35 pg/ 00 ml, CdU < 2 pg/g creatinine, and HgU < 5 pg/g creatinine. ( 2) The exposed workers should have been uninterruptedly exposed either to Cd, or Pb, or Hg vapour, for at least one year before the study and at the time of the examination the following biological criteria had to be fulfilled:
Cd group: CdU > 2 pg/g creatinine, PbB < 35 pg/ 100 ml, HgU < 5 pg/g creatinine Pb group: PbB 35 pg/100 ml, CdU < 2 pg/g creatinine, HgU < 5 pg/g creatinine Hg group: HgU > 5 pg/g creatinine, PbB < 35 Mg/ 100 ml, CdU < 2 pg/g creatinine. ( 3) The medical history of the control and exposed. workers should not show cardiovascular diseases such as hypertension or coronary insufficiency, kidney diseases of known causes-for example, renal stones or congenital abnormalities-or diabetes mellitus. (4) Subjects on a sodium poor diet, as reflected by a low urinary concentration of Na+ (<35 mmol/g creatinine, corresponding to a natriuresis < 50 mmol/24 h), were excluded since an abnormally low intake of sodium may be associated with a pronounced increase of urinary kallikrein activity. '4 Thirty four control workers (seven with excessive exposure to heavy metals, 13 with health problems, and 14 with low urinary sodium) and 52 metal exposed workers (40 with mixed occupational exposure to heavy metals, six with health problems, and six with low urinary sodium) did not meet these selection criteria and were excluded from the definitive study population that comprised 333 subjects subdivided into a group of 193 control workers, a Cd group of 64 subjects (40 currently exposed and 24 removed from exposure), a Hg group of 53 subjects, and a Pb group of 23 subjects.
BLOOD AND URINE SAMPLING
At the time of examination a sample of venous blood (20 ml) and a spot urine sample (50 ml) were collected from each participant. Syringes, tubes, and urine containers were previously checked for lack of heavy metal contamination. Blood samples were divided as follows: 5 ml were transferred to a polyethylene tube (containing 50 p1 Na,-EDTA, 10% w/v) for heavy metal analysis and the remainder was kept in an empty tube for separation of serum. The blood samples were kept at 4°C and the serum samples at -20°C. Immediately after the urine samples were obtained an aliquot of 4 ml was transferred to a tube containing 04 ml phosphate buffer 1 mol/l, pH (containing 0 20% NaN3) and kept at -20°C until the analysis of #2-microglobulin, retinol binding protein, and albumin; another urine aliquot of 6 ml was kept at -20°C without preservative until the measurement of kallikrein activity and the concentration of sodium; the remainder of the spot urine sample was kept at 4°C for subsequent analysis of heavy metals, total proteinuria, and total aminoaciduria.
BIOLOGICAL ANALYSES
The internal exposure to the metals was assessed by measuring CdU, HgU, PbB, and zinc protoporphyrin in erythrocytes (ZPP) according to standardised techniques.'"'7 The following were measured, in serum: creatinine by the method of Heinegard and Tiderstrom'8 slightly modified for automation and f2-microglobulin by latex immunoassay'9; and in urine: creatinine,20 total proteins,2' aminoacids,'5 ,B2-microglobulin, retinol binding protein, and albumin by latex immunoassay,'9 and sodium (Na+-U) by flame atomic absorption.22
The activity ofkallikrein in urine was measured on an aliquot of the urine sample kept at -20°C for not longer than 30 days, since decrease ( > 5%) in urinary kallikrein activity occurs after a longer storage period. The enzyme assay is based on the amidolytic property of this protease using as substrate, the chromogenic tripeptide H-D-valyl-L-leucyl-Larginine-p-nitroanilide (S-2266) purchased from Kabi Diagnostica (Stockholm, Sweden). The assay was carried out at 37°C in Tris-HCl buffer (0-2 mol/ 1, pH 8&2) according to the end point method described by Bonner and Marin-Grez.2" Preliminary assays have shown that the final concentration of aprotinin (Trasylol, Bayer, Leverkusen, FRG) in the assay mixture should be 100 instead of 10 KIU/ml to obtain more than 95% inhibition of kallikrein activity in the blank assay. For assays yielding an absorbance increase at 405 nm higher than 0.190/ 30 min, a diluted (two or fourfold) urine aliquot was used. It is known that the metals have no direct inhibitory effect'" on kallikrein activity, at least in the range of concentrations found in the urine of exposed workers.
In the 64 cadmium workers and in a subgroup of57 age matched control subjects the serum concentrations of Na+ and K+ were determined by flame atomic absorption 22 and the concentration ofurinary We have also examined whether the urinary kallikrein activity significantly differed between the 46 Cd workers without signs of renal dysfunction and 40 7-284-8 mmol/g creatinine) did not differ from that found in the control workers. Subdivision of the total population according to CdU and PbB confirmed that the increased urinary concentration of Na+ was exclusively associated with the increased Cd body burden and again no interaction between exposures to Pb and Cd was found (table 6) .
The urinary aldosterone concentration was significantly lower in the Cd group than in the age matched control workers (table 7) . This was associated with a statistically significant increase of the serum K+ level and a significantly decreased serum Na+ concentration. The biological changes observed in cadmium workers did not significantly differ between those currently exposed or removed from exposure (table 8) . The cadmium workers were also subdivided in two subgroups according to the presence or absence ofan increased microproteinuria (as defined above) or on the basis of PbB (< and >218 pg/100 ml). The urine aldosterone and the serum electrolyte concentrations did not differ between the subgroups (results not shown). A low but highly statistically significant Pearson correlation coefficient (n = 121: Cd group + age matched control group) was found between the urinary kallikrein activity and urinary aldosterone concentration (log normal distributions: r = 0-33, p < 0-001 tKallikrein urine (kg) = 0 54 (U/g creat).
Discussion Renal kallikrein, a serine protease that liberates the decapeptide lysylbradykinin (kallidin) from the plasma protein kininogen, is synthesised by the distal part of the nephron26 2 and is released into the urine. The activity of the renal kallikrein kinin system has usually been assessed in man and animals by measuring urinary kallikrein excretion.
The present study shows that workers exposed to Cd on average for 10 years had a significantly lower kallikrein concentration in urine than control subjects. This suggests that an increased Cd body burden may not only interfere with the function of the proximal tubule and the glomerulus but may also affect the distal nephron. Our observation on workers agrees with that of other investigators on rats chronically intoxicated with Cd."13 The effect of Cd on kallikrein production may occur independently of the presence of functional changes in the proximal tubule, since a statistically significant decreased urinary kallikrein activity was also found in the subgroup of Cd workers without microproteinuria. Despite the fact that no correlation was found between urinary kallikrein activity and CdU, the effect of Cd at the distal nephron level seems to result from the increased Cd body burden and not from a concomitant exposure to Pb. This effect is irreversible since the urinary kallikrein concentration remains low after removal from exposure to Cd. To be included in the present study, the workers had to have a normal blood pressure without medical treatment. Our results suggest that despite their reduced production of kallikrein, the Cd workers maintained their blood pressure in the normal range by stimulating a compensatory reaction, the reduction of aldosterone production (as reflected by urinary aldosterone) which led to an increased urinary excretion of sodium and an increased serum concentration of potassium. This is supported by the finding of a statistically significant correlation between the urinary kallikrein activity and urinary aldosterone concentration. Ohman and Karlberg also reported that in normal subjects, urinary kallikrein and aldosterone are usually related, suggesting a functional relationship between the two.28 In Cd workers the reduction ofkallikrein production by the kidney is probably responsible for the decreased aldosterone release rather than the opposite, since experiments on isolated rat kidney have shown that aldosterone has no direct effect on kallikrein release.29
A study on hypertensive patients and normal subjects did not show that the renin angiotensin aldosterone system directly influences the kallikrein kinin system. 30 It is therefore possible that Cd workers whose compensatory reactions to a reduction of kallikrein production are already jeopardised may be at risk of developing hypertension. This study suggests that exposure to Cd alone may not be sufficient to induce hypertension, even in subjects with Cd induced microproteinuria but it may interact with genetic or acquired conditions that impair other mechanisms of blood pressure regulation to stimulate the development of hypertension. Such interactions may be difficult to assess by an epidemiological approach and may explain why clinical studies on subjects occupationally or environmentally exposed to Cd have provided conflicting results. Our observation, however, supports the recommendation that subjects with hypertension should not be exposed to Cd. Monitoring urinary kallikrein activity or concentration might also be useful for the health surveillance of workers exposed to Cd, even in those without microproteinuria.
The present study does not indicate that moderate exposure to Hg or Pb interferes with renal kallikrein activity. Chmielnicka et al have found a decreased urinary kallikrein activity in Pb workers with PbB ranging from 40 to 80 pg/dl.3' Boscolo et al reported also a significant decrease in urinary kallikrein activity in workers exposed to Pb on average for four years and aged more than 33 but they could not detect any significant effect on young exposed workers. 32 They speculated that with increasing age, the kidney may become more susceptible to damage by Pb. Since in both studies, however, exposure to Cd which is a frequent contaminant in the Pb industry was not assessed,3' 32 the possibility that Cd may have been responsible for the decreased urinary kallikrein found by these authors cannot be excluded. Furthermore, it should be pointed out that the enzymic assay used in these two investigations is based on the esterolytic activity of kallikrein (substrate: Na-benzoyl-L-arginine ethyl ester) which is a less specific assay for this enzyme than the amidolytic assay23 used in our study since, in addition to kallikrein, a nonkallikrein esterase might contribute to the total esterase activity in human urine.33 Since recent investigations, however, have shown good correlations between human kallikrein activity assays dependent on its enzymatic activity (kinin generation, S-2266, AcPheArgOEt) and on its immunoreactivity (RIA and ELISA), 3435 the first hypothesis (concomitant exposure to cadmium) seems more likely to explain the results of Chmielnicka et a3' and Boscolo et aP32 on workers exposed to lead, although the second hypothesis (interference of non-kallikrein esterolytic activity) cannot be completely ruled out.
